Neurochemical Research 2001-06-01

Remyelination in vitro following protein kinase C activator-induced demyelination.

S Pouly, J M Matthieu, P Honegger

Index: Neurochem. Res. 26(6) , 619-27, (2001)

Full Text: HTML

Abstract

In previous work we found that mezerein, a C kinase activator, as well as basic fibroblast growth factor (FGF-2) induce demyelination and partial oligodendrocyte dedifferentiation in highly differentiated aggregating brain cell cultures. Here we show that following protein kinase C activator-induced demyelination, effective remyelination occurs. We found that mezerein or FGF-2 caused a transient increase in DNA synthesis following a pronounced decrease of the myelin markers myelin basic protein and 2',3'-cyclic nucleotide 3'-phosphohydrolase. Both oligodendrocytes and astrocytes were involved in this mitogenic response. Within 17 days after demyelination, myelin was restored to the level of the untreated controls. Transient mitotic activity was indispensable for remyelination. The present results suggest that myelinating oligodendrocytes retain the capacity to reenter the cell cycle, and that this plasticity is important for the regeneration of the oligodendrocyte lineage and remyelination. Although it cannot be excluded that a quiescent population of oligodendrocyte precursor cells was present in the aggregates and able to proliferate, differentiate and remyelinate, we could not find evidence supporting this view.


Related Compounds

Related Articles:

Models of acute inflammation in the ear.

2003-01-01

[Methods Mol. Biol. 225 , 129-37, (2003)]

Gateway synthesis of daphnane congeners and their protein kinase C affinities and cell-growth activities.

2011-08-01

[Nature Chemistry 3(8) , 615-9, (2011)]

Analysis of daphnane orthoesters in poisonous Australian pimelea species by liquid chromatography-tandem mass spectrometry.

2010-06-23

[J. Agric. Food Chem. 58(12) , 7482-7, (2010)]

Synergistic induction of apoptosis in human leukemia cells (U937) exposed to bryostatin 1 and the proteasome inhibitor lactacystin involves dysregulation of the PKC/MAPK cascade.

2001-04-01

[Blood 97(7) , 2105-14, (2001)]

E6201, a novel kinase inhibitor of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase-1 and mitogen-activated protein kinase/extracellular signal-regulated kinase kinase kinase-1: in vivo effects on cutaneous inflammatory responses by topical administration.

2010-10-01

[J. Pharmacol. Exp. Ther. 335(1) , 23-31, (2010)]

More Articles...